Blood cancers

Podcast: Treating multiple myeloma is ‘a marathon, not a sprint’

Sponsored by Amgen Australia Pty Ltd

Although advances in the management of multiple myeloma have improved survival, treatment in the relapsed or refractory setting remains challenging. In this podcast Professor Paul Richardson and Professor Miles Prince talk through their considerations in the treatment of multiple myeloma and reflect on the differing perspectives that come from having a broader range of treatment ...

Already a member?

Login to keep reading.

© 2021 the limbic